Home » Newsletters » BioWorld Science

BioWorld Science

May 18, 2004

View Archived Issues

Mood improvements found with levetiracetam in bipolar disorder

Further data on alefacept in the treatment of psoriasis

Insmed's rhIGFBP-3 selected as a candidate therapy in Defense Department grant

Phase I trial begins with HIV vaccine based on Avant's Therapore technology

Debiopharm signs license agreement for development of ZT-1 as Alzheimer's treatment

Evotec establishes discovery agreements with Guilford and Roche

Genta withdraws Genasense NDA

Access begins second oral drug delivery research collaboration

Swedish authorities approve shelf-life extension for Multiferon

Inflazyme discontinues further development of GH-9001

Nutra Pharma enters agreement with Healthforce to bring to market Infectech's technology

NewNeural reaches key milestone in development program

Phase I clinical trials commence with SB-743921 for treatment of solid tumors

Mobic to be marketed in Japan by Daiichi Pharmaceutical

Antibiotic activity of iclaprim investigated in vitro, in vivo

GH reported to improve weight and stimulate mucosal healing in mice with colitis

Preclinical evidence of the efficacy of thioredoxin-1 in IBD

SB-265610 reduces the severity of colitis in a mouse model

Potential benefits of clonidine in continuous diabetic diarrhea

BAL-4815 pharmacokinetics determined in humans

Clinical improvements found with ABT-874 in Crohn's disease

DDW highlights: Lower serum transaminase levels found with IDN-6556 in hepatitis C patients

RUTI vaccine beneficial in M. tuberculosis infection

Telavancin in vitro activity, special population pharmacokinetics studied

GSK presents two series of cannabinoid CB2 agonists for pain and other uses

Pfizer claims dual D2/5-HT2A antagonists and their use in schizophrenia

New antibacterial 11,12-modified erythromycin analogues under study at Enanta

Novel carbazole-based antitumor agents identified by French researchers

Tularik patent covers novel MCH-R2 ligands with utility in obesity and other disorders

Elan scientists describe beta-secretase inhibitors for AD therapy

Novel HCV NS3 protease inhibitors prepared and tested at 3D Genoscience

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...